Journal of Clinical Microbiology · 2008 · 17 citations · 29 references
MedicineMolecular BiologyMolecular GeneticsMolecular DiagnosticsPharmacogeneticsPharmacogenomicsDrug Resistance GenomicsMolecular Diagnosis Of ParasitesResistance DiagnosisResistance GenesGenetic Markers Of ResistanceMalaria GenomicsMolecular Detection AssaysMolecular Drug ResistanceMultiplex Polymerase Chain Reaction (Pcr)Parasite Drug ResistancePlasmodium FalciparumResistance Gene Polymorphism Analysis
Drug resistance in Plasmodium falciparum is a serious public health threat in the countries where this organism is endemic. Since resistance has been associated with specific single-nucleotide polymorphisms (SNPs) in parasite genes, molecular markers are becoming useful surrogates for monitoring the emergence and dispersion of drug resistance. In this study, a multiplex PCR (mPCR) and oligonucleotide microarray method was developed for the detection of these SNPs in genes encoding chloroquine resistance transporter (Pfcrt), multidrug resistance 1 (Pfmdr1), dihydrofolate reductase (Pfdhfr), dihydropteroate synthetase (Pfdhps), and ATPase 6 (PfATPase6) of P. falciparum. The results show that DNA microarray technology, combined with mPCR, is a promising and time-saving tool that supports conventional detection methods, allowing sensitive, accurate, simultaneous analysis of the SNPs associated with drug resistance in P. falciparum.
29
Weltgesundheitsorganisation · 2005 · 3.8K citations
Artemisinins target the SERCA of Plasmodium falciparum
Ursula Eckstein‐Ludwig, Richard Webb, Iris D. A. van Goethem et al. · Nature · 2003 · 1K citations
Genetic Analysis of the Human Malaria Parasite <i>Plasmodium falciparum</i>
David Walliker, Isabella A. Quakyi, Thomas E. Wellems et al. · Science · 1987 · 760 citations